GRN mutations in symptomatic and presymptomatic carriers were linked to reduced PGRN levels in blood in relation to HC, presymptomatic carriers of other mutations (C9orf72, MAPT), and patients with FTD. This evidence concerns the gene MAPT and frontotemporal dementia.